Recognizing the signs can save lives: Raising awareness of male breast cancer

Recognizing the signs can save lives: Raising awareness of male breast cancer


A A MAN A MAN BEING A MAN BEING DIAGNOSED A MAN BEING DIAGNOSED WITH A MAN BEING DIAGNOSED WITH
CANCER A MAN BEING DIAGNOSED WITH
CANCER IS A MAN BEING DIAGNOSED WITH
CANCER IS RARE A MAN BEING DIAGNOSED WITH
CANCER IS RARE BUT A MAN BEING DIAGNOSED WITH
CANCER IS RARE BUT RECOGNIZING CANCER IS RARE BUT RECOGNIZING CANCER IS RARE BUT RECOGNIZING
THE CANCER IS RARE BUT RECOGNIZING
THE SIGNS CANCER IS RARE BUT RECOGNIZING
THE SIGNS COULD CANCER IS RARE BUT RECOGNIZING
THE SIGNS COULD MEAN CANCER IS RARE BUT RECOGNIZING
THE SIGNS COULD MEAN LIFE CANCER IS RARE BUT RECOGNIZING
THE SIGNS COULD MEAN LIFE OR THE SIGNS COULD MEAN LIFE OR THE SIGNS COULD MEAN LIFE OR
DEATH. THE SIGNS COULD MEAN LIFE OR
DEATH. EYEWITNESS THE SIGNS COULD MEAN LIFE OR
DEATH. EYEWITNESS NEWS THE SIGNS COULD MEAN LIFE OR
DEATH. EYEWITNESS NEWS REPORTER DEATH. EYEWITNESS NEWS REPORTER DEATH. EYEWITNESS NEWS REPORTER
JEREMY DEATH. EYEWITNESS NEWS REPORTER
JEREMY BAKER DEATH. EYEWITNESS NEWS REPORTER
JEREMY BAKER SHOWS DEATH. EYEWITNESS NEWS REPORTER
JEREMY BAKER SHOWS HOW DEATH. EYEWITNESS NEWS REPORTER
JEREMY BAKER SHOWS HOW EARLY JEREMY BAKER SHOWS HOW EARLY JEREMY BAKER SHOWS HOW EARLY
DETECTION JEREMY BAKER SHOWS HOW EARLY
DETECTION AND JEREMY BAKER SHOWS HOW EARLY
DETECTION AND DYNAMIC JEREMY BAKER SHOWS HOW EARLY
DETECTION AND DYNAMIC TESTING DETECTION AND DYNAMIC TESTING DETECTION AND DYNAMIC TESTING
IS DETECTION AND DYNAMIC TESTING
IS KEY DETECTION AND DYNAMIC TESTING
IS KEY TO DETECTION AND DYNAMIC TESTING
IS KEY TO SAVING DETECTION AND DYNAMIC TESTING
IS KEY TO SAVING YOURSELF DETECTION AND DYNAMIC TESTING
IS KEY TO SAVING YOURSELF AND IS KEY TO SAVING YOURSELF AND IS KEY TO SAVING YOURSELF AND
FUTURE IS KEY TO SAVING YOURSELF AND
FUTURE GENERATIONS. FUTURE GENERATIONS. FUTURE GENERATIONS.
THE FUTURE GENERATIONS.
THE AMERICAN FUTURE GENERATIONS.
THE AMERICAN CANCER FUTURE GENERATIONS.
THE AMERICAN CANCER SOCIETY THE AMERICAN CANCER SOCIETY THE AMERICAN CANCER SOCIETY
ESTIMATES THE AMERICAN CANCER SOCIETY
ESTIMATES ABOUT THE AMERICAN CANCER SOCIETY
ESTIMATES ABOUT TWENTY THE AMERICAN CANCER SOCIETY
ESTIMATES ABOUT TWENTY SIX ESTIMATES ABOUT TWENTY SIX ESTIMATES ABOUT TWENTY SIX
HUNDRED ESTIMATES ABOUT TWENTY SIX
HUNDRED SEVENTY ESTIMATES ABOUT TWENTY SIX
HUNDRED SEVENTY NEW ESTIMATES ABOUT TWENTY SIX
HUNDRED SEVENTY NEW CASES ESTIMATES ABOUT TWENTY SIX
HUNDRED SEVENTY NEW CASES OF HUNDRED SEVENTY NEW CASES OF HUNDRED SEVENTY NEW CASES OF
INVASIVE HUNDRED SEVENTY NEW CASES OF
INVASIVE CANCER HUNDRED SEVENTY NEW CASES OF
INVASIVE CANCER WILL HUNDRED SEVENTY NEW CASES OF
INVASIVE CANCER WILL BE INVASIVE CANCER WILL BE INVASIVE CANCER WILL BE
DIAGNOSED INVASIVE CANCER WILL BE
DIAGNOSED IN INVASIVE CANCER WILL BE
DIAGNOSED IN THE INVASIVE CANCER WILL BE
DIAGNOSED IN THE U.S. INVASIVE CANCER WILL BE
DIAGNOSED IN THE U.S. THIS INVASIVE CANCER WILL BE
DIAGNOSED IN THE U.S. THIS YEAR DIAGNOSED IN THE U.S. THIS YEAR DIAGNOSED IN THE U.S. THIS YEAR
IN DIAGNOSED IN THE U.S. THIS YEAR
IN MEN DIAGNOSED IN THE U.S. THIS YEAR
IN MEN AND DIAGNOSED IN THE U.S. THIS YEAR
IN MEN AND FOR DIAGNOSED IN THE U.S. THIS YEAR
IN MEN AND FOR MEN DIAGNOSED IN THE U.S. THIS YEAR
IN MEN AND FOR MEN THE DIAGNOSED IN THE U.S. THIS YEAR
IN MEN AND FOR MEN THE LIFETIME IN MEN AND FOR MEN THE LIFETIME IN MEN AND FOR MEN THE LIFETIME
RISK IN MEN AND FOR MEN THE LIFETIME
RISK OF IN MEN AND FOR MEN THE LIFETIME
RISK OF GETTING IN MEN AND FOR MEN THE LIFETIME
RISK OF GETTING CANCER IN MEN AND FOR MEN THE LIFETIME
RISK OF GETTING CANCER IS RISK OF GETTING CANCER IS RISK OF GETTING CANCER IS
ABOUT RISK OF GETTING CANCER IS
ABOUT ONE RISK OF GETTING CANCER IS
ABOUT ONE IN RISK OF GETTING CANCER IS
ABOUT ONE IN 1000 RISK OF GETTING CANCER IS
ABOUT ONE IN 1000 DAYS RISK OF GETTING CANCER IS
ABOUT ONE IN 1000 DAYS FOR ABOUT ONE IN 1000 DAYS FOR ABOUT ONE IN 1000 DAYS FOR
STAGE. ABOUT ONE IN 1000 DAYS FOR
STAGE. THE ABOUT ONE IN 1000 DAYS FOR
STAGE. THE SURVIVAL ABOUT ONE IN 1000 DAYS FOR
STAGE. THE SURVIVAL FOR ABOUT ONE IN 1000 DAYS FOR
STAGE. THE SURVIVAL FOR MALE STAGE. THE SURVIVAL FOR MALE STAGE. THE SURVIVAL FOR MALE
AND STAGE. THE SURVIVAL FOR MALE
AND FEMALE STAGE. THE SURVIVAL FOR MALE
AND FEMALE CANCER STAGE. THE SURVIVAL FOR MALE
AND FEMALE CANCER IS STAGE. THE SURVIVAL FOR MALE
AND FEMALE CANCER IS THE STAGE. THE SURVIVAL FOR MALE
AND FEMALE CANCER IS THE SAME AND FEMALE CANCER IS THE SAME AND FEMALE CANCER IS THE SAME
BUT AND FEMALE CANCER IS THE SAME
BUT MALE AND FEMALE CANCER IS THE SAME
BUT MALE TEND AND FEMALE CANCER IS THE SAME
BUT MALE TEND TO AND FEMALE CANCER IS THE SAME
BUT MALE TEND TO PRESENT AND FEMALE CANCER IS THE SAME
BUT MALE TEND TO PRESENT AT AND FEMALE CANCER IS THE SAME
BUT MALE TEND TO PRESENT AT A BUT MALE TEND TO PRESENT AT A BUT MALE TEND TO PRESENT AT A
LATER BUT MALE TEND TO PRESENT AT A
LATER STAGE BUT MALE TEND TO PRESENT AT A
LATER STAGE THAT BUT MALE TEND TO PRESENT AT A
LATER STAGE THAT WOMEN BUT MALE TEND TO PRESENT AT A
LATER STAGE THAT WOMEN DO. BUT MALE TEND TO PRESENT AT A
LATER STAGE THAT WOMEN DO. DR. LATER STAGE THAT WOMEN DO. DR. LATER STAGE THAT WOMEN DO. DR.
MIRIAM LATER STAGE THAT WOMEN DO. DR.
MIRIAM ELMI LATER STAGE THAT WOMEN DO. DR.
MIRIAM ELMI A LATER STAGE THAT WOMEN DO. DR.
MIRIAM ELMI A SURGICAL MIRIAM ELMI A SURGICAL MIRIAM ELMI A SURGICAL
ONCOLOGIST MIRIAM ELMI A SURGICAL
ONCOLOGIST WITH MIRIAM ELMI A SURGICAL
ONCOLOGIST WITH THE MIRIAM ELMI A SURGICAL
ONCOLOGIST WITH THE MAYOR’S ONCOLOGIST WITH THE MAYOR’S ONCOLOGIST WITH THE MAYOR’S
CANCER ONCOLOGIST WITH THE MAYOR’S
CANCER CENTER ONCOLOGIST WITH THE MAYOR’S
CANCER CENTER WITHIN ONCOLOGIST WITH THE MAYOR’S
CANCER CENTER WITHIN UTI ONCOLOGIST WITH THE MAYOR’S
CANCER CENTER WITHIN UTI HEALTH CANCER CENTER WITHIN UTI HEALTH CANCER CENTER WITHIN UTI HEALTH
SAN CANCER CENTER WITHIN UTI HEALTH
SAN ANTONIO CANCER CENTER WITHIN UTI HEALTH
SAN ANTONIO SAYS CANCER CENTER WITHIN UTI HEALTH
SAN ANTONIO SAYS THERE CANCER CENTER WITHIN UTI HEALTH
SAN ANTONIO SAYS THERE ARE SAN ANTONIO SAYS THERE ARE SAN ANTONIO SAYS THERE ARE
SIGNS SAN ANTONIO SAYS THERE ARE
SIGNS MEN SAN ANTONIO SAYS THERE ARE
SIGNS MEN SHOULD SAN ANTONIO SAYS THERE ARE
SIGNS MEN SHOULD LOOK SAN ANTONIO SAYS THERE ARE
SIGNS MEN SHOULD LOOK OUT SAN ANTONIO SAYS THERE ARE
SIGNS MEN SHOULD LOOK OUT FOR SAN ANTONIO SAYS THERE ARE
SIGNS MEN SHOULD LOOK OUT FOR A SIGNS MEN SHOULD LOOK OUT FOR A SIGNS MEN SHOULD LOOK OUT FOR A
PALPABLE SIGNS MEN SHOULD LOOK OUT FOR A
PALPABLE LUMP. SIGNS MEN SHOULD LOOK OUT FOR A
PALPABLE LUMP. FOR SIGNS MEN SHOULD LOOK OUT FOR A
PALPABLE LUMP. FOR INSTANCE PALPABLE LUMP. FOR INSTANCE PALPABLE LUMP. FOR INSTANCE
IT’S PALPABLE LUMP. FOR INSTANCE
IT’S SOMETHING PALPABLE LUMP. FOR INSTANCE
IT’S SOMETHING THAT PALPABLE LUMP. FOR INSTANCE
IT’S SOMETHING THAT WE PALPABLE LUMP. FOR INSTANCE
IT’S SOMETHING THAT WE NEED PALPABLE LUMP. FOR INSTANCE
IT’S SOMETHING THAT WE NEED TO IT’S SOMETHING THAT WE NEED TO IT’S SOMETHING THAT WE NEED TO
WORRY IT’S SOMETHING THAT WE NEED TO
WORRY ABOUT IT’S SOMETHING THAT WE NEED TO
WORRY ABOUT OR IT’S SOMETHING THAT WE NEED TO
WORRY ABOUT OR DISCHARGE IT’S SOMETHING THAT WE NEED TO
WORRY ABOUT OR DISCHARGE OR WORRY ABOUT OR DISCHARGE OR WORRY ABOUT OR DISCHARGE OR
ANY WORRY ABOUT OR DISCHARGE OR
ANY CHANGES WORRY ABOUT OR DISCHARGE OR
ANY CHANGES TO WORRY ABOUT OR DISCHARGE OR
ANY CHANGES TO THE WORRY ABOUT OR DISCHARGE OR
ANY CHANGES TO THE IN WORRY ABOUT OR DISCHARGE OR
ANY CHANGES TO THE IN TERMS WORRY ABOUT OR DISCHARGE OR
ANY CHANGES TO THE IN TERMS OF ANY CHANGES TO THE IN TERMS OF ANY CHANGES TO THE IN TERMS OF
SHAPE ANY CHANGES TO THE IN TERMS OF
SHAPE OR ANY CHANGES TO THE IN TERMS OF
SHAPE OR POSITION ANY CHANGES TO THE IN TERMS OF
SHAPE OR POSITION MUCH ANY CHANGES TO THE IN TERMS OF
SHAPE OR POSITION MUCH LIKE SHAPE OR POSITION MUCH LIKE SHAPE OR POSITION MUCH LIKE
POSTMENOPAUSAL SHAPE OR POSITION MUCH LIKE
POSTMENOPAUSAL WOMEN. POSTMENOPAUSAL WOMEN. POSTMENOPAUSAL WOMEN.
THE POSTMENOPAUSAL WOMEN.
THE TREATMENT POSTMENOPAUSAL WOMEN.
THE TREATMENT FOR POSTMENOPAUSAL WOMEN.
THE TREATMENT FOR MALE POSTMENOPAUSAL WOMEN.
THE TREATMENT FOR MALE CANCER THE TREATMENT FOR MALE CANCER THE TREATMENT FOR MALE CANCER
IS THE TREATMENT FOR MALE CANCER
IS SIMILAR THE TREATMENT FOR MALE CANCER
IS SIMILAR WE THE TREATMENT FOR MALE CANCER
IS SIMILAR WE TREAT THE TREATMENT FOR MALE CANCER
IS SIMILAR WE TREAT CANCER IS SIMILAR WE TREAT CANCER IS SIMILAR WE TREAT CANCER
WITH IS SIMILAR WE TREAT CANCER
WITH EITHER IS SIMILAR WE TREAT CANCER
WITH EITHER A IS SIMILAR WE TREAT CANCER
WITH EITHER A LUMPECTOMY IS SIMILAR WE TREAT CANCER
WITH EITHER A LUMPECTOMY WHERE WITH EITHER A LUMPECTOMY WHERE WITH EITHER A LUMPECTOMY WHERE
WE WITH EITHER A LUMPECTOMY WHERE
WE REMOVE WITH EITHER A LUMPECTOMY WHERE
WE REMOVE PART WITH EITHER A LUMPECTOMY WHERE
WE REMOVE PART OF WITH EITHER A LUMPECTOMY WHERE
WE REMOVE PART OF THE WITH EITHER A LUMPECTOMY WHERE
WE REMOVE PART OF THE OR WITH EITHER A LUMPECTOMY WHERE
WE REMOVE PART OF THE OR A WE REMOVE PART OF THE OR A WE REMOVE PART OF THE OR A
TOTAL WE REMOVE PART OF THE OR A
TOTAL MASTECTOMY WE REMOVE PART OF THE OR A
TOTAL MASTECTOMY WHERE WE REMOVE PART OF THE OR A
TOTAL MASTECTOMY WHERE WE TOTAL MASTECTOMY WHERE WE TOTAL MASTECTOMY WHERE WE
REMOVE TOTAL MASTECTOMY WHERE WE
REMOVE ALL TOTAL MASTECTOMY WHERE WE
REMOVE ALL THE TOTAL MASTECTOMY WHERE WE
REMOVE ALL THE TISSUE. TOTAL MASTECTOMY WHERE WE
REMOVE ALL THE TISSUE. SOME TOTAL MASTECTOMY WHERE WE
REMOVE ALL THE TISSUE. SOME OF REMOVE ALL THE TISSUE. SOME OF REMOVE ALL THE TISSUE. SOME OF
THE REMOVE ALL THE TISSUE. SOME OF
THE RISK REMOVE ALL THE TISSUE. SOME OF
THE RISK FACTORS REMOVE ALL THE TISSUE. SOME OF
THE RISK FACTORS MEN REMOVE ALL THE TISSUE. SOME OF
THE RISK FACTORS MEN FACE REMOVE ALL THE TISSUE. SOME OF
THE RISK FACTORS MEN FACE WHEN THE RISK FACTORS MEN FACE WHEN THE RISK FACTORS MEN FACE WHEN
IT THE RISK FACTORS MEN FACE WHEN
IT COMES THE RISK FACTORS MEN FACE WHEN
IT COMES TO THE RISK FACTORS MEN FACE WHEN
IT COMES TO CANCER THE RISK FACTORS MEN FACE WHEN
IT COMES TO CANCER INCLUDE IT COMES TO CANCER INCLUDE IT COMES TO CANCER INCLUDE
OLDER IT COMES TO CANCER INCLUDE
OLDER AGE IT COMES TO CANCER INCLUDE
OLDER AGE WITH IT COMES TO CANCER INCLUDE
OLDER AGE WITH MOST IT COMES TO CANCER INCLUDE
OLDER AGE WITH MOST MEN OLDER AGE WITH MOST MEN OLDER AGE WITH MOST MEN
DIAGNOSED OLDER AGE WITH MOST MEN
DIAGNOSED IN OLDER AGE WITH MOST MEN
DIAGNOSED IN THEIR OLDER AGE WITH MOST MEN
DIAGNOSED IN THEIR 60S. DIAGNOSED IN THEIR 60S. DIAGNOSED IN THEIR 60S.
EXPOSURE DIAGNOSED IN THEIR 60S.
EXPOSURE TO DIAGNOSED IN THEIR 60S.
EXPOSURE TO ESTROGEN DIAGNOSED IN THEIR 60S.
EXPOSURE TO ESTROGEN SUCH DIAGNOSED IN THEIR 60S.
EXPOSURE TO ESTROGEN SUCH AS EXPOSURE TO ESTROGEN SUCH AS EXPOSURE TO ESTROGEN SUCH AS
FOR EXPOSURE TO ESTROGEN SUCH AS
FOR HORMONE EXPOSURE TO ESTROGEN SUCH AS
FOR HORMONE THERAPY. EXPOSURE TO ESTROGEN SUCH AS
FOR HORMONE THERAPY. A EXPOSURE TO ESTROGEN SUCH AS
FOR HORMONE THERAPY. A FAMILY FOR HORMONE THERAPY. A FAMILY FOR HORMONE THERAPY. A FAMILY
HISTORY FOR HORMONE THERAPY. A FAMILY
HISTORY OF FOR HORMONE THERAPY. A FAMILY
HISTORY OF CANCER FOR HORMONE THERAPY. A FAMILY
HISTORY OF CANCER LIVER HISTORY OF CANCER LIVER HISTORY OF CANCER LIVER
DISEASE HISTORY OF CANCER LIVER
DISEASE AND HISTORY OF CANCER LIVER
DISEASE AND ALSO HISTORY OF CANCER LIVER
DISEASE AND ALSO OBESITY. HISTORY OF CANCER LIVER
DISEASE AND ALSO OBESITY. IF DISEASE AND ALSO OBESITY. IF DISEASE AND ALSO OBESITY. IF
THEY DISEASE AND ALSO OBESITY. IF
THEY HAVE DISEASE AND ALSO OBESITY. IF
THEY HAVE A DISEASE AND ALSO OBESITY. IF
THEY HAVE A VERY DISEASE AND ALSO OBESITY. IF
THEY HAVE A VERY STRONG DISEASE AND ALSO OBESITY. IF
THEY HAVE A VERY STRONG FAMILY THEY HAVE A VERY STRONG FAMILY THEY HAVE A VERY STRONG FAMILY
HISTORY THEY HAVE A VERY STRONG FAMILY
HISTORY FOR THEY HAVE A VERY STRONG FAMILY
HISTORY FOR CANCER THEY HAVE A VERY STRONG FAMILY
HISTORY FOR CANCER THEY HISTORY FOR CANCER THEY HISTORY FOR CANCER THEY
USUALLY HISTORY FOR CANCER THEY
USUALLY GET HISTORY FOR CANCER THEY
USUALLY GET SENT HISTORY FOR CANCER THEY
USUALLY GET SENT TO HISTORY FOR CANCER THEY
USUALLY GET SENT TO US HISTORY FOR CANCER THEY
USUALLY GET SENT TO US FOR USUALLY GET SENT TO US FOR USUALLY GET SENT TO US FOR
INSTANCE USUALLY GET SENT TO US FOR
INSTANCE IN USUALLY GET SENT TO US FOR
INSTANCE IN OUR USUALLY GET SENT TO US FOR
INSTANCE IN OUR HIGH USUALLY GET SENT TO US FOR
INSTANCE IN OUR HIGH RISK INSTANCE IN OUR HIGH RISK INSTANCE IN OUR HIGH RISK
CLINIC INSTANCE IN OUR HIGH RISK
CLINIC AND INSTANCE IN OUR HIGH RISK
CLINIC AND WE INSTANCE IN OUR HIGH RISK
CLINIC AND WE COULD INSTANCE IN OUR HIGH RISK
CLINIC AND WE COULD TEST INSTANCE IN OUR HIGH RISK
CLINIC AND WE COULD TEST THEM CLINIC AND WE COULD TEST THEM CLINIC AND WE COULD TEST THEM
GENETICALLY CLINIC AND WE COULD TEST THEM
GENETICALLY TO CLINIC AND WE COULD TEST THEM
GENETICALLY TO SEE CLINIC AND WE COULD TEST THEM
GENETICALLY TO SEE IF CLINIC AND WE COULD TEST THEM
GENETICALLY TO SEE IF THEY GENETICALLY TO SEE IF THEY GENETICALLY TO SEE IF THEY
CARRY GENETICALLY TO SEE IF THEY
CARRY A GENETICALLY TO SEE IF THEY
CARRY A GENE GENETICALLY TO SEE IF THEY
CARRY A GENE SUCH GENETICALLY TO SEE IF THEY
CARRY A GENE SUCH AS GENETICALLY TO SEE IF THEY
CARRY A GENE SUCH AS BROCKETT CARRY A GENE SUCH AS BROCKETT CARRY A GENE SUCH AS BROCKETT
TOO. CARRY A GENE SUCH AS BROCKETT
TOO. THAT CARRY A GENE SUCH AS BROCKETT
TOO. THAT PUTS CARRY A GENE SUCH AS BROCKETT
TOO. THAT PUTS THEM CARRY A GENE SUCH AS BROCKETT
TOO. THAT PUTS THEM AT CARRY A GENE SUCH AS BROCKETT
TOO. THAT PUTS THEM AT HIGH TOO. THAT PUTS THEM AT HIGH TOO. THAT PUTS THEM AT HIGH
RISK TOO. THAT PUTS THEM AT HIGH
RISK FOR TOO. THAT PUTS THEM AT HIGH
RISK FOR A TOO. THAT PUTS THEM AT HIGH
RISK FOR A FUTURE TOO. THAT PUTS THEM AT HIGH
RISK FOR A FUTURE CANCER. RISK FOR A FUTURE CANCER. RISK FOR A FUTURE CANCER.
GETTING RISK FOR A FUTURE CANCER.
GETTING THAT RISK FOR A FUTURE CANCER.
GETTING THAT GENETIC RISK FOR A FUTURE CANCER.
GETTING THAT GENETIC TESTING RISK FOR A FUTURE CANCER.
GETTING THAT GENETIC TESTING IS GETTING THAT GENETIC TESTING IS GETTING THAT GENETIC TESTING IS
OF GETTING THAT GENETIC TESTING IS
OF THE GETTING THAT GENETIC TESTING IS
OF THE UTMOST GETTING THAT GENETIC TESTING IS
OF THE UTMOST IMPORTANCE OF THE UTMOST IMPORTANCE OF THE UTMOST IMPORTANCE
BECAUSE OF THE UTMOST IMPORTANCE
BECAUSE IF OF THE UTMOST IMPORTANCE
BECAUSE IF THE OF THE UTMOST IMPORTANCE
BECAUSE IF THE MAN OF THE UTMOST IMPORTANCE
BECAUSE IF THE MAN IS OF THE UTMOST IMPORTANCE
BECAUSE IF THE MAN IS A OF THE UTMOST IMPORTANCE
BECAUSE IF THE MAN IS A CARRIER BECAUSE IF THE MAN IS A CARRIER BECAUSE IF THE MAN IS A CARRIER
ROCKET BECAUSE IF THE MAN IS A CARRIER
ROCKET TOO BECAUSE IF THE MAN IS A CARRIER
ROCKET TOO THERE’S BECAUSE IF THE MAN IS A CARRIER
ROCKET TOO THERE’S A BECAUSE IF THE MAN IS A CARRIER
ROCKET TOO THERE’S A 50 BECAUSE IF THE MAN IS A CARRIER
ROCKET TOO THERE’S A 50 PERCENT ROCKET TOO THERE’S A 50 PERCENT ROCKET TOO THERE’S A 50 PERCENT
CHANCE ROCKET TOO THERE’S A 50 PERCENT
CHANCE THAT

One thought on “Recognizing the signs can save lives: Raising awareness of male breast cancer

Leave a Reply

Your email address will not be published. Required fields are marked *